TURBO-CHARGE YOUR REGULATORY COMPLIANCE: WHY A SINGLE SYSTEM APPROACH IS BEST
August 5, 2013 | Pharma Compliance Monitor
Starting August 1, 2013 manufacturers of bio-pharmaceuticals and medical devices are required to begin collecting and tracking payment, transfer and ownership information when the Physician Payments Sunshine Act (PPSA) goes into effect. The purpose of PPSA is to reduce the potential for conﬂicts of interest that US-based health care providers (HCPs) or teaching hospitals could face as a result of their relationships with manufacturers…
Appian provides a low-code development platform that accelerates the creation of high-impact business applications. Many of the world’s largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance.